Corbo, Christian .
HRN: 23-01-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
MUPIROCIN 2%, 15G (TUBE)
05/20/2023
05/27/2023
IV
Topical
Bid
Pcap D
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes